SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-22-005360
Filing Date
2022-02-14
Accepted
2022-02-14 17:01:24
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETSUBJECT CO 1VIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTERVIKING GLOBAL OPPORTUNITIES PARENT GP LLCVIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10033255_sc13ga.htm SC 13G/A 277012
  Complete submission text file 0001140361-22-005360.txt   279002
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91478 | Film No.: 22634212
SIC: 2834 Pharmaceutical Preparations